Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 3Polfa Tarchomin
02 1Alexon Healthcare
03 2Antibiotice SA
04 1Anwita Drugs & Chemicals Pvt Ltd
05 2Chongqing Huapont Pharmaceutical Co. Ltd
06 3Pannon
07 1Reyoung pharmaceutical
08 1Shenyang Shuangding Pharmaceutical
09 3Umedica Laboratories Pvt Ltd
10 2Varichem Pharmaceuticals Pvt Ltd
01 5Rifampicin
02 1Rifampicin; Isoniazid
03 12Rifampin
04 1Rifampin; Isoniazid
01 4CAPSULE
02 1Capsule
03 3Film Coated Tablet
04 3Hard Capsule
05 3Injection
06 1PELLET
07 1Powder for Injection
08 1SUSPENSION
09 2capsules
01 10.45g
02 1100MG/5ML
03 5150MG
04 1150MG; 100MG
05 1300; 150MG
06 5300MG
07 1300MG/5ML
08 2450MG
09 160%
10 1600MG
01 4China
02 3Hungary
03 5India
04 3Poland
05 2Romania
06 2Zimbabwe
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 150MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 300MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2026
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2026
Dosage : Hard Capsule
Dosage Strength : 150MG; 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 450MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 450MG
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Powder for Injection
Dosage Strength : 0.45g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging :
Regulatory Info :
Dosage : Powder for Injection
Dosage Strength : 0.45g
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging : Blister of 10s
Approval Date :
Application Number : 90034
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 150MG
Brand Name : URIFA
Approval Date :
Application Number : 90034
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 300MG
Packaging : Blister of 10s
Approval Date :
Application Number : 90034
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 300MG
Brand Name : URIFA
Approval Date :
Application Number : 90034
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : URIFA
Dosage Form : CAPSULE
Dosage Strength : 450MG
Packaging : Blister of 10s
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging : Blister of 10s
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 450MG
Brand Name : URIFA
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : Zimbabwe
Brand Name : Rifacure
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Zimbabwe
Packaging :
Regulatory Info : Generic
Dosage : CAPSULE
Dosage Strength : 150MG
Brand Name : Rifacure
Approval Date :
Application Number :
Registration Country : Zimbabwe
Regulatory Info : Generic
Registration Country : Zimbabwe
Brand Name : Rifacure
Dosage Form : SUSPENSION
Dosage Strength : 100MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Zimbabwe
Packaging :
Regulatory Info : Generic
Dosage : SUSPENSION
Dosage Strength : 100MG/5ML
Brand Name : Rifacure
Approval Date :
Application Number :
Registration Country : Zimbabwe
